These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12913200)

  • 21. Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy.
    Eichler F; Mahmood A; Loes D; Bezman L; Lin D; Moser HW; Raymond GV
    Arch Neurol; 2007 May; 64(5):659-64. PubMed ID: 17502464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adrenoleukodystrophy].
    Kálmánchey R; Molzer B; Illés Z; Princzinger A; Sólyom J
    Orv Hetil; 1997 Apr; 138(14):867-71. PubMed ID: 9162896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of X-linked adrenoleukodystrophy.
    Moser HW
    NeuroRx; 2006 Apr; 3(2):246-53. PubMed ID: 16554262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
    Moser HW
    J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter.
    Tourbah A; Stievenart JL; Iba-Zizen MT; Lubetzki C; Baumann N; Eymard B; Moser HW; Lyon-Caen O; Cabanis EA
    Arch Neurol; 1997 May; 54(5):586-92. PubMed ID: 9152115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-linked adrenoleukodystrophy.
    Moser HW; Mahmood A; Raymond GV
    Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients.
    Oz G; Tkác I; Charnas LR; Choi IY; Bjoraker KJ; Shapiro EG; Gruetter R
    Neurology; 2005 Feb; 64(3):434-41. PubMed ID: 15699371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of Clinical and Imaging Characteristics of 48 X-Linked Adrenoleukodystrophy Patients: Our Experience from a University Hospital.
    Bhat M; Natarajan A; Chandra SR; Christropher R; Netravathi M
    Neurol India; 2022; 70(4):1554-1561. PubMed ID: 36076658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of central motor conduction after bone marrow transplantation in adrenoleukodystrophy.
    Hitomi T; Mezaki T; Tsujii T; Kinoshita M; Tomimoto H; Ikeda A; Shimohama S; Okazaki T; Uchiyama T; Shibasaki H
    J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):373-5. PubMed ID: 12588932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenoleukodystrophy: clinical analysis of 9 Taiwanese children.
    Liang JS; Lee WT; Hwu WL; Peng SS; Chu LW; Wang PJ; Shen YZ
    Acta Paediatr Taiwan; 2004; 45(5):272-7. PubMed ID: 15868809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
    Moser HW; Moser AB; Hollandsworth K; Brereton NH; Raymond GV
    J Mol Neurosci; 2007 Sep; 33(1):105-13. PubMed ID: 17901554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
    Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
    Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
    [No Abstract]   [Full Text] [Related]  

  • 33. MR spectroscopic imaging of normal-appearing white matter in adrenoleukodystrophy.
    Izquierdo M; Adamsbaum C; Benosman A; Aubourg P; Bittoun J
    Pediatr Radiol; 2000 Sep; 30(9):621-9. PubMed ID: 11009301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative proton magnetic resonance spectroscopy of children with adrenoleukodystrophy before and after hematopoietic stem cell transplantation.
    Wilken B; Dechent P; Brockmann K; Finsterbusch J; Baumann M; Ebell W; Korenke GC; Pouwels PJ; Hanefeld FA; Frahm J
    Neuropediatrics; 2003 Jun; 34(5):237-46. PubMed ID: 14598229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI demyelination pattern and clinical course in a child with cerebral X-linked adrenoleukodystrophy (X-ALD).
    Nowak J; Löbel U; Wölfl M; Schlegel PG; Warmuth-Metz M
    Acta Radiol Open; 2015 Apr; 4(4):2047981615573655. PubMed ID: 25848550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The X-linked adrenoleukodystrophy (X-ALD) and oxidative stress.
    Al-Omar MA
    J Herb Pharmacother; 2006; 6(3-4):125-34. PubMed ID: 17317654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy.
    Pierpont EI; Nascene DR; Shanley R; Kenney-Jung DL; Ziegler RS; Miller WP; Gupta AO; Lund TC; Orchard PJ; Eisengart JB
    Neurology; 2020 Aug; 95(5):e591-e600. PubMed ID: 32616675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive effects with Lorenzo's oil.
    Siva N
    Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.